Cyfuse Biomedical Selected for Social Impact Project Leveraging AI/DX

TOKYO, Jul 15 (Pulse News Wire) – Cyfuse Biomedical K.K. (4892.F) was selected for the FY2027 Social Impact Project promoted by Fukuoka Bio Community.

The project aims to accelerate research and development of innovative medical products using advanced technologies such as AI and DX. This initiative builds upon Cyfuse's ongoing efforts to develop regenerative and cellular medical products utilizing its proprietary "Bio 3D Printing" technology. Since its founding as a spin-off from Kyushu University, the company has actively engaged in regional revitalization activities through collaboration with local institutions, businesses, and government entities.

The selection underscores the company’s commitment to enhancing its product development capabilities and strengthening its business foundation. The impact of this project on Cyfuse's performance will be reflected in the fiscal year ending December 31, 2027 (January 1, 2027 to December 31, 2027), with an expected upper limit of ¥20 million. Through this partnership, Cyfuse plans to further accelerate its global expansion initiatives, aiming to integrate regional revitalization-driven value enhancement with long-term growth strategies in international markets.